» Articles » PMID: 20553485

Survival Mechanisms of Pathogenic Mycobacterium Tuberculosis H37Rv

Overview
Journal FEBS J
Specialty Biochemistry
Date 2010 Jun 18
PMID 20553485
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacterium tuberculosis H(37)Rv is a highly successful pathogen and its success fully relies on its ability to utilize macrophages for its replication and, more importantly, the macrophage should remain viable to host the Mycobacterium. Despite the fact that these phagocytes are usually very effective in internalizing and clearing most of the bacteria, M. tuberculosis H(37)Rv has evolved a number of very effective survival strategies, including: (a) the inhibition of phagosome-lysosome fusion; (b) the inhibition of phagosome acidification; (c) the recruitment and retention of tryptophan-aspartate containing coat protein on phagosomes to prevent their delivery to lysosomes; and (d) the expression of members of the host-induced repetitive glycine-rich protein family of proteins. However, the mechanisms by which M. tuberculosis H(37)Rv enters the host cell, circumvents host defenses and spreads to neighboring cell are not completely understood. Therefore, a better understanding of host-pathogen interaction is essential if the global tuberculosis pandemic is ever to be controlled. This review addresses some of the pathogenic strategies of the M. tuberculosis H(37)Rv that aids in its survival and pathogenicity.

Citing Articles

Repurposing of apoptotic inducer drugs against Mycobacterium tuberculosis.

Nyambo K, Soko V, Tapfuma K, Motaung B, Adu-Amankwaah F, Julius L Sci Rep. 2025; 15(1):7109.

PMID: 40016256 PMC: 11868625. DOI: 10.1038/s41598-025-91096-8.


Toward Virulence Inhibition: Beyond Cell Wall.

Kotliarova M, Shumkov M, Goncharenko A Microorganisms. 2025; 13(1).

PMID: 39858789 PMC: 11767696. DOI: 10.3390/microorganisms13010021.


Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals.

Lyu J, Narum D, Baldwin S, Larsen S, Bai X, Griffith D Front Immunol. 2024; 15:1427559.

PMID: 39717773 PMC: 11663721. DOI: 10.3389/fimmu.2024.1427559.


Mycobacterium tuberculosis: The Mechanism of Pathogenicity, Immune Responses, and Diagnostic Challenges.

Mohammadnabi N, Shamseddin J, Emadi M, Bodaghi A, Varseh M, Shariati A J Clin Lab Anal. 2024; 38(23):e25122.

PMID: 39593272 PMC: 11632860. DOI: 10.1002/jcla.25122.


Deciphering the role of VapBC13 and VapBC26 toxin antitoxin systems in the pathophysiology of Mycobacterium tuberculosis.

Sharma A, Singh N, Bhasin M, Tiwari P, Chopra P, Varadarajan R Commun Biol. 2024; 7(1):1417.

PMID: 39478197 PMC: 11525840. DOI: 10.1038/s42003-024-06998-6.